Two New Appointees at the NCI

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 9
Volume 4
Issue 9

BETHESDA, Md--Carol Mans-field, MD, professor of radiation oncology, Thomas Jefferson University, Philadelphia, has been appointed chief of NCI's Radiation Research Program. She is former president of the American Radium Society and the American Cancer Society, Philadelphia Division.

BETHESDA, Md--Carol Mans-field, MD, professor of radiation oncology,Thomas Jefferson University, Philadelphia, has been appointedchief of NCI's Radiation Research Program. She is former presidentof the American Radium Society and the American Cancer Society,Philadelphia Division.

Kenneth Cowan, MD, head of the NCI Medicinal Breast Cancer Section,will serve as acting chief of the Medicine Branch, temporarilyreplacing Robert Wittes, MD, acting director of the Division ofCancer Treatment.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Specialties including neurosurgery, radiation oncology, and neuro-rehabilitation all play a notable role in the care of patients with brain tumors.
Treatment-related toxicities during neuro-oncology therapy appear well managed with dose modifications and treatment cycle holds.
The phase 3 NIVOSTOP trial evaluated an anti–PD-1 immunotherapy, nivolumab, in a patient population similar in the KEYNOTE-689 trial.
CAR T-cell therapies appear to be an evolving modality in the treatment of those with intracranial tumors, said Sylvia Kurz, MD, PhD.
Opportunities to further reduce relapses include pembrolizumab-based combination therapy and evaluating the agent’s contribution before and after surgery.